Doctors Without Borders/Médecins Sans Frontières (MSF) TB Symposium

Doctors Without Borders/Médecins Sans Frontières (MSF) TB Symposium: "Support new approaches to R&D * The lack of TB drug development is a result of the failure of current profitdriven drug research and development model. The TB community must engage in the World Health OrganizationÕs Intergovernmental Working Group on Innovation, Intellectual Property and Public Health to establish a global R&D framework to help design new ways of setting R&D priorities and financing. * With respect to TB drug development, participants of the New York symposium support current discussion at the WHO for a treaty on essential health R&D that addresses the question of who pays for essential medical R&D and de-links incentives from drug prices, instead rewarding the impact of inventions according to health care outcomes."